跳至主要内容
临床试验/JPRN-UMIN000014129
JPRN-UMIN000014129已完成未知

Assessment of safety and effectiveness: the clinical use of tofogliflozin in patients with type 2 diabetes mellitus - AYUMI

Japan Association for Diabetes Education and Care0 个研究点目标入组 10,000 人开始时间: 2014年5月31日最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
10,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Hypersensitivity to tofogliflozin 2.Patients who had severe ketosis or diabetic coma or precoma 3.Severe infection or trauma, perioperative 4.End stage renal disease with hemodialysis or peritoneal dialysis 5.Patients whose participation is deemed inappropriate at the discretion of the attending physician

研究者

相似试验

Assessment of safety and effectiveness: the clinical... | 临床试验